Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. more
Time Frame | CELZ | Sector | S&P500 |
---|---|---|---|
1-Week Return | -7.3% | -0.94% | -2.6% |
1-Month Return | -15.89% | -5.08% | -1.08% |
3-Month Return | -27.42% | -10.62% | 3.45% |
6-Month Return | -41.19% | -6.18% | 8.57% |
1-Year Return | -54.03% | 1.98% | 24.3% |
3-Year Return | -89.2% | -0.93% | 25.58% |
5-Year Return | -99.04% | 33.84% | 84.07% |
10-Year Return | -99.97% | 102.52% | 185.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 165.50K | 164.50K | 87.75K | 88.60K | 9.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.4,"profit":true},{"date":"2021-12-31","value":53.02,"profit":true},{"date":"2022-12-31","value":53.53,"profit":true},{"date":"2023-12-31","value":5.44,"profit":true}] |
Cost of Revenue | 45.50K | 50.60K | 47.95K | 28.49K | 3.60K | [{"date":"2019-12-31","value":89.93,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":94.77,"profit":true},{"date":"2022-12-31","value":56.31,"profit":true},{"date":"2023-12-31","value":7.12,"profit":true}] |
Gross Profit | 120.00K | 113.90K | 39.80K | 60.11K | 5.40K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":94.92,"profit":true},{"date":"2021-12-31","value":33.17,"profit":true},{"date":"2022-12-31","value":50.09,"profit":true},{"date":"2023-12-31","value":4.5,"profit":true}] |
Gross Margin | 72.51% | 69.24% | 45.36% | 67.84% | 60.00% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":95.5,"profit":true},{"date":"2021-12-31","value":62.56,"profit":true},{"date":"2022-12-31","value":93.57,"profit":true},{"date":"2023-12-31","value":82.75,"profit":true}] |
Operating Expenses | 1.25M | 1.23M | 3.17M | 10.30M | 5.53M | [{"date":"2019-12-31","value":12.13,"profit":true},{"date":"2020-12-31","value":11.92,"profit":true},{"date":"2021-12-31","value":30.72,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":53.68,"profit":true}] |
Operating Income | (1.13M) | (1.11M) | (3.13M) | (10.24M) | (5.62M) | [{"date":"2019-12-31","value":-113016800,"profit":false},{"date":"2020-12-31","value":-111483500,"profit":false},{"date":"2021-12-31","value":-312594900,"profit":false},{"date":"2022-12-31","value":-1024437200,"profit":false},{"date":"2023-12-31","value":-562013200,"profit":false}] |
Total Non-Operating Income/Expense | (9.25M) | (36.44M) | 18.06M | 200.66K | 636.10K | [{"date":"2019-12-31","value":-51.21,"profit":false},{"date":"2020-12-31","value":-201.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":1.11,"profit":true},{"date":"2023-12-31","value":3.52,"profit":true}] |
Pre-Tax Income | (8.48M) | (36.33M) | 19.21M | (10.14M) | (5.29M) | [{"date":"2019-12-31","value":-44.16,"profit":false},{"date":"2020-12-31","value":-189.08,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-52.8,"profit":false},{"date":"2023-12-31","value":-27.52,"profit":false}] |
Income Taxes | 1.90M | 1.23M | 4.28M | (100.33K) | (4.00) | [{"date":"2019-12-31","value":44.3,"profit":true},{"date":"2020-12-31","value":28.74,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.34,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (10.38M) | (37.55M) | 14.93M | (10.04M) | (5.29M) | [{"date":"2019-12-31","value":-69.5,"profit":false},{"date":"2020-12-31","value":-251.48,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-67.26,"profit":false},{"date":"2023-12-31","value":-35.4,"profit":false}] |
Income From Continuous Operations | (8.48M) | (36.33M) | 19.21M | (10.14M) | (9.82M) | [{"date":"2019-12-31","value":-44.16,"profit":false},{"date":"2020-12-31","value":-189.08,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-52.8,"profit":false},{"date":"2023-12-31","value":-51.13,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (10.38M) | (37.55M) | 14.93M | (10.04M) | (5.29M) | [{"date":"2019-12-31","value":-69.5,"profit":false},{"date":"2020-12-31","value":-251.48,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-67.26,"profit":false},{"date":"2023-12-31","value":-35.4,"profit":false}] |
EPS (Diluted) | (269.64) | (37.08) | 5.02 | (0.52) | (3.06) | [{"date":"2019-12-31","value":-5371.41,"profit":false},{"date":"2020-12-31","value":-738.66,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-10.36,"profit":false},{"date":"2023-12-31","value":-60.96,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
CELZ | |
---|---|
Cash Ratio | 18.92 |
Current Ratio | 19.13 |
Quick Ratio | 19.12 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CELZ | |
---|---|
ROA (LTM) | -36.27% |
ROE (LTM) | -57.03% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CELZ | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.05 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.95 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CELZ | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 328.91 |
P/B | 0.56 |
Price/FCF | NM |
EV/R | 56.07 |
EV/Ebitda | NM |
Creative Medical Technology Holdings Inc (CELZ) share price today is $2.17
Yes, Indians can buy shares of Creative Medical Technology Holdings Inc (CELZ) on Vested. To buy Creative Medical Technology Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CELZ stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Creative Medical Technology Holdings Inc (CELZ) via the Vested app. You can start investing in Creative Medical Technology Holdings Inc (CELZ) with a minimum investment of $1.
You can invest in shares of Creative Medical Technology Holdings Inc (CELZ) via Vested in three simple steps:
The 52-week high price of Creative Medical Technology Holdings Inc (CELZ) is $7.44. The 52-week low price of Creative Medical Technology Holdings Inc (CELZ) is $1.96.
The price-to-earnings (P/E) ratio of Creative Medical Technology Holdings Inc (CELZ) is
The price-to-book (P/B) ratio of Creative Medical Technology Holdings Inc (CELZ) is 0.56
The dividend yield of Creative Medical Technology Holdings Inc (CELZ) is 0.00%
The market capitalization of Creative Medical Technology Holdings Inc (CELZ) is $3.62M
The stock symbol (or ticker) of Creative Medical Technology Holdings Inc is CELZ